ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers.
FDA Advisers Call for Cardiovascular-Safety Assessment of New Di...Courtesy MedPage Today Infectious Disease Thu, 07/03/2008 - 10:37
ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers. Popular products More related itemsDiabetes drugs given 'too soon'
FDA Advisers Would End Asthma Indications for Two...
FDA Advisers Consider Safety of Long-Acting Beta...
Vicks V4500 FilterFree Humidifier
The Care & Keeping of You: The Body Book for Girls...
|
Popular by tags WeekMonth |
Post new comment